ArticleBMC musculoskeletal disorders2025
Generic health status improves after non-surgically and surgically treated hip abductor tendon pathology: a retrospective study of ninety-seven female patients.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInsertional hip abductor tendon pathology (tendinopathy or tears of gluteus medius and/or minimus tendons) are increasingly recognized as the main cause of lateral hip pain. This study aims to evaluate generic health status in patients with lateral hip pain due to Magnetic Resonance Imaging (MRI) verified hip abductor tendon pathology using the EQ-5D-5L and compare these findings with a matched national population norm.
methodsData from patients with lateral hip pain, referred to our hospital from 2017-2023, was retrospectively reviewed. Females aged 18+ years, with positive clinical tests and MRI verified hip abductor tendon pathology, who had completed the EQ-5D-5L at relevant timepoints, were included. Our treatment algorithm consisted of a baseline physiotherapist led intervention (patient education followed by 3-months un-supervised training). Surgery was offered to patients who, after the intervention, had recalcitrant lateral hip pain and MRI verified tendon tears. Post hoc two treatment groups were identified. The EQ-index scores were calculated from individual health profiles using a national value set. The student's t-test was used to compare groups. Summary statistics are used, including numbers of patients and proportions of categorical responses for the five EQ-5D dimensions. To compare responses between groups, the Fisher's exact test was used.
resultsNinety-seven female patients were included; 48 (57±12 years) received rehabilitation only (REHAB) and 49 (59±11 years) underwent subsequent surgery (SURG). At baseline, the mean EQ-index was inferior to population norms. After 3 months of rehabilitation, EQ-index (p<0.0001) and EQ-VAS (p=0.004) improved in REHAB, but not in SURG (EQ-index: p=0.32, EQ-VAS: p=0.22). Twelve months after surgery, EQ-index (p<0.0001) and EQ-VAS (p<0.0001) improved and, notably, the dimension "pain/discomfort" was comparable to population norms (p=0.788).
conclusionGeneric health status in female patients suffering from lateral hip pain due to hip abductor tendon pathology is severely affected compared to a national population norm measured with the EQ-5D-5L. Generic health status may improve after three months of patient education and rehabilitation in some cases, while surgery may improve health status three months postoperative in the remaining cases.
trial registrationThe study is registered at the Central Denmark Region List of Research Projects (Jr nr: 1-16-02-761-17 and 1-16-02-125-19).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.